Literature DB >> 36113105

Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021.

Don C Des Jarlais1, Czarina N Behrends2, Maria A Corcorran3, Sara N Glick3, David C Perlman4, Shashi N Kapadia2,5, Xinlin Lu1, Jonathan Feelemyer1, Paul LaKosky6, Stephanie M Prohaska6, Bruce R Schackman2.   

Abstract

Many syringe services programs (SSPs) have established trusting, long-term relationships with their clients and are well situated to provide COVID-19 vaccinations. We examined characteristics and practices of SSPs in the United States that reported providing COVID-19 vaccinations to their clients and obstacles to vaccinating people who inject drugs (PWID). We surveyed SSPs in September 2021 to examine COVID-19 vaccination practices through a supplement to the 2020 Dave Purchase Memorial survey. Of 153 SSPs surveyed, 73 (47.7%) responded to the supplement; 24 of 73 (32.9%) reported providing on-site COVID-19 vaccinations. Having provided hepatitis and influenza vaccinations was significantly associated with providing COVID-19 vaccinations (70.8% had provided them vs 28.6% had not; P = .002). Obstacles to providing vaccination included lack of appropriate facilities, lack of funding, lack of trained staff, and vaccine hesitancy among PWID. SSPs are underused as vaccination providers. Many SSPs are well situated to provide COVID-19 vaccinations to PWID, and greater use of SSPs as vaccination providers is needed.

Entities:  

Keywords:  COVID-19; HIV; hepatitis C; syringe services programs; vaccination

Mesh:

Substances:

Year:  2022        PMID: 36113105      PMCID: PMC9574299          DOI: 10.1177/00333549221120241

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   3.117


  7 in total

1.  Expansion of Syringe Service Programs in the United States, 2015-2018.

Authors:  Don C Des Jarlais; Jonathan Feelemyer; Paul LaKosky; Kathryn Szymanowski; Kamyar Arasteh
Journal:  Am J Public Health       Date:  2020-02-20       Impact factor: 9.308

2.  Costs of opioid overdose education and naloxone distribution in New York City.

Authors:  Czarina N Behrends; Sarah Gutkind; Emily Winkelstein; Monique Wright; Jennifer Dolatshahi; Alice Welch; Denise Paone; Hillary V Kunins; Bruce R Schackman
Journal:  Subst Abus       Date:  2021-10-19       Impact factor: 3.984

3.  Doing harm reduction better: syringe exchange in the United States.

Authors:  Don C Des Jarlais; Courtney McKnight; Cullen Goldblatt; David Purchase
Journal:  Addiction       Date:  2009-02-10       Impact factor: 6.526

4.  Stigma at every turn: Health services experiences among people who inject drugs.

Authors:  Catherine E Paquette; Jennifer L Syvertsen; Robin A Pollini
Journal:  Int J Drug Policy       Date:  2018-04-30

5.  Association of Social and Demographic Factors With COVID-19 Incidence and Death Rates in the US.

Authors:  Monita Karmakar; Paula M Lantz; Renuka Tipirneni
Journal:  JAMA Netw Open       Date:  2021-01-04

6.  Evidence of Social and Structural COVID-19 Disparities by Sexual Orientation, Gender Identity, and Race/Ethnicity in an Urban Environment.

Authors:  Megan M Ruprecht; Xinzi Wang; Amy K Johnson; Jiayi Xu; Dylan Felt; Siobhan Ihenacho; Patrick Stonehouse; Caleb W Curry; Catherine DeBroux; Diogo Costa; Gregory Phillips Ii
Journal:  J Urban Health       Date:  2020-12-01       Impact factor: 3.671

7.  "They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City.

Authors:  Brandon Muncan; Suzan M Walters; Jerel Ezell; Danielle C Ompad
Journal:  Harm Reduct J       Date:  2020-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.